|
|||||
|
|
Healthcare resource utilization and costs assessment of type 2 diabetes patients initiating exenatide BID or glargine: a retrospective database analysis |
|
| Authors: | Pawaskar Manjiri Zagar Anthony Sugihara Tomoko Shi Lizheng |
| Institution: | Eli Lilly and Company and Lilly USA, LLC, Indianapolis, IN 46285, USA. pawaskar_manjiri@lilly.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |